InvestorsHub Logo
Followers 31
Posts 9570
Boards Moderated 0
Alias Born 09/25/2016

Re: crazyjogger925 post# 55372

Sunday, 07/08/2018 8:44:21 PM

Sunday, July 08, 2018 8:44:21 PM

Post# of 60952
Revenues are derived from the patent licensing of the syringe to date imo. Going public opens a lot of doors to potential marketing and selling the product themselves. Possible production too imo.

Revenues are undisclosed so anyone saying $2B probably smokes too much weed.

I’m sure licensing the patent has done well enough for them to seek distribution of the technology themselves though. I’d be doing the same thing. imo.

After the merger I see $10-$20 a share here based on what I read about this stick-proof syringe.